Mansucript was submitted May, 2001. The next communication was this rejection letter:
September 20, 2001
Larry M. Weisenthal, MD
Weisenthal Cancer Group
15140 Transistor Lane
Huntington Beach, CA 92649
Dear Dr. Weisenthal:
I regret to have to tell you that our editorial board and our editorial reviewers decline to publish your article on drug resistance testing. I feel particularly badly because I was the one who invited you to prepare the article. The reviewers feel that the subject is just too controversial and that the journal should not show the appearance of supporting the use of such testing.
I do apologize that we will not be publishing your article and am returning copies of the manuscript herewith. We will, of course, send you the promised honorarium of $500.
James F. McCarthy Senior Vice President, Editorial